Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

被引:0
作者
Gras-Martin, Laura [1 ,2 ,3 ]
Plaza-Diaz, Adrian [1 ,2 ]
Zarate-Tamames, Borja [1 ,2 ]
Vera-Artazcoz, Paula [2 ,3 ,4 ]
Torres, Olga H. [2 ,3 ,5 ]
Bastida, Carla [6 ,7 ]
Soy, Dolors [6 ,7 ]
Ruiz-Ramos, Jesus [1 ,2 ,3 ]
机构
[1] Hosp Santa Creu i St Pau, Pharm Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] Inst Recerca St Pau IR St PAU, Sat Quinti 77-79, Barcelona 08041, Spain
[3] Univ Autonoma Barcelona, Dept Med, Bellaterra 08193, Spain
[4] Hosp Santa Creu i St Pau, Intens Care Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[5] Hosp Samta Creu i St Pau, Internal Med Dept, Geriatr Unit, St Antoni Maria Claret 167, Barcelona 08025, Spain
[6] Hosp Clin Barcelona, Pharm Dept, Div Med, Villarroel 170, Barcelona 08036, Spain
[7] Univ Barcelona, Fac Pharm, Dept Pharmacol, Toxicol & Therapeut Chem, Ave de Joan XXIII 27-31, Barcelona 08028, Spain
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
pharmacokinetics; pharmacodynamics; critically ill patients; antibiotic; exposure; target attainment; risk factors; RENAL REPLACEMENT THERAPY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INTENSIVE-CARE-UNIT; LOW-EFFICIENCY DIALYSIS; PIPERACILLIN POPULATION PHARMACOKINETICS; VENTILATOR-ASSOCIATED PNEUMONIA; NEGATIVE BACTERIAL-INFECTIONS; ACUTE KIDNEY INJURY; CONTINUOUS-INFUSION; SEPTIC PATIENTS;
D O I
10.3390/antibiotics13090801
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
(1) Background: Knowledge about the behavior of antibiotics in critically ill patients has been increasing in recent years. Some studies have concluded that a high percentage may be outside the therapeutic range. The most likely cause of this is the pharmacokinetic variability of critically ill patients, but it is not clear which factors have the greatest impact. The aim of this systematic review is to identify risk factors among critically ill patients that may exhibit significant pharmacokinetic alterations, compromising treatment efficacy and safety. (2) Methods: The search included the PubMed, Web of Science, and Embase databases. (3) Results: We identified 246 observational studies and ten clinical trials. The most studied risk factors in the literature were renal function, weight, age, sex, and renal replacement therapy. Risk factors with the greatest impact included renal function, weight, renal replacement therapy, age, protein or albumin levels, and APACHE or SAPS scores. (4) Conclusions: The review allows us to identify which critically ill patients are at a higher risk of not reaching therapeutic targets and helps us to recognize the extensive number of risk factors that have been studied, guiding their inclusion in future studies. It is essential to continue researching, especially in real clinical practice and with clinical outcomes.
引用
收藏
页数:27
相关论文
共 309 条
[71]   Antibiotic dose optimization in critically ill patients [J].
Cotta, M. O. ;
Roberts, J. A. ;
Lipman, J. .
MEDICINA INTENSIVA, 2015, 39 (09) :563-572
[72]   Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens [J].
Couffignal, Camille ;
Pajot, Olivier ;
Laouenan, Cedric ;
Burdet, Charles ;
Foucrier, Arnaud ;
Wolff, Michel ;
Armand-Lefevre, Laurence ;
Mentre, France ;
Massias, Laurent .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) :1022-1034
[73]   New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients [J].
Cristallini, Stefano ;
Hites, Maya ;
Kabtouri, Hakim ;
Roberts, Jason A. ;
Beumier, Marjorie ;
Cotton, Frederic ;
Lipman, Jeffrey ;
Jacobs, Frederique ;
Vincent, Jean-Louis ;
Creteur, Jacques ;
Taccone, Fabio Silvio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) :4750-4756
[74]   An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration [J].
D'Arcy, Deirdre M. ;
Casey, Eoin ;
Gowing, Caitriona M. ;
Donnelly, Maria B. ;
Corrigan, Owen I. .
BMC PHARMACOLOGY & TOXICOLOGY, 2012, 13
[75]   Pharmacokinetics of ertapenem in burns patients [J].
Dailly, E. ;
Arnould, J. F. ;
Fraissinet, F. ;
Naux, E. ;
de la Bouraliere, M. A. Letard ;
Bouquie, R. ;
Deslandes, G. ;
Jolliet, P. ;
Le Floch, R. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (01) :48-52
[76]   Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study [J].
De Corte, Thomas ;
Verhaeghe, Jarne ;
Dhaese, Sofie ;
Van Vooren, Sarah ;
Boelens, Jerina ;
G. Verstraete, Alain ;
Stove, Veronique ;
Ongenae, Femke ;
De Bus, Liesbet ;
Depuydt, Pieter ;
Van Hoecke, Sofie ;
J. De Waele, Jan .
ANNALS OF INTENSIVE CARE, 2023, 13 (01)
[77]   Vancomycin for Dialytic Therapy in Critically Ill Patients: Analysis of Its Reduction and the Factors Associated with Subtherapeutic Concentrations [J].
de Freitas, Fernanda Moreira ;
Zamoner, Welder ;
dos Reis, Pamela Falbo ;
Balbi, Andre Luis ;
Ponce, Daniela .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (18) :1-12
[78]   Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen [J].
de Montmollin, Etienne ;
Bouadma, Lila ;
Gault, Nathalie ;
Mourvillier, Bruno ;
Mariotte, Eric ;
Chemam, Sarah ;
Massias, Laurent ;
Papy, Emmanuelle ;
Tubach, Florence ;
Wolff, Michel ;
Sonneville, Romain .
INTENSIVE CARE MEDICINE, 2014, 40 (07) :998-1005
[79]   Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients [J].
De Waele, Jan J. ;
Lipman, J. ;
Akova, M. ;
Bassetti, M. ;
Dimopoulos, G. ;
Kaukonen, M. ;
Koulenti, D. ;
Martin, C. ;
Montravers, P. ;
Rello, J. ;
Rhodes, A. ;
Udy, A. A. ;
Starr, T. ;
Wallis, S. C. ;
Roberts, J. A. .
INTENSIVE CARE MEDICINE, 2014, 40 (09) :1340-1351
[80]   Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial [J].
De Waele, Jan J. ;
Carrette, S. ;
Carlier, M. ;
Stove, V. ;
Boelens, J. ;
Claeys, G. ;
Leroux-Roels, I. ;
Hoste, E. ;
Depuydt, P. ;
Decruyenaere, J. ;
Verstraete, A. G. .
INTENSIVE CARE MEDICINE, 2014, 40 (03) :380-387